Status:
NOT_YET_RECRUITING
MgSO4 as Adjuvants to Bupivacaine vs Neostigmine in TAP Block in Cesarean Section
Lead Sponsor:
Assiut University
Conditions:
Cesarean Section
Eligibility:
FEMALE
19-40 years
Phase:
PHASE2
PHASE3
Brief Summary
The aim of this study is to compare the duration of analgesia obtained by addition of Neostigmine versus MgSO4 as adjuvants to bupivacaine in TAP block in patients undergoing Cesarean Section and to e...
Detailed Description
Caesarean section (CS) is one of the most operations in the world. Effective postoperative analgesia after it is very important because it encourages breast feeding and facilitates early ambulation an...
Eligibility Criteria
Inclusion
- Age from 19 to 40 years old
- Singleton pregnencies with a gestational age of at least 37 weeks
- American society of anesthesiologists (ASA) physical state I , II
- patients undergoing spinal anesthesia for cesarean delivery via Pfannenstiel incision with exteriorization of the uterus.
Exclusion
- Patient's refusal
- Age \< 19 or \> 40 years
- Height\<150 cm, weight \< 60 kg, body mass index (BMI) ≥40 kg/m2.
- Contraindications to spinal anesthesia (Coagulopathy, increased intracranial pressure, or local skin infection).
- Cardio-respiratory conditions
- Convulsions
- Inability to comprehend or participate in the pain scoring system.
- Bleeding diathesis
- Known allergy to any drugs used in this study
Key Trial Info
Start Date :
July 20 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT06513013
Start Date
July 20 2024
End Date
December 1 2026
Last Update
July 22 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.